Backscattering coherent Stokes Raman scattering (sCiSsoRS) for real-time cancer diagnostics

This project aims to enhance real-time cancer diagnosis during surgery by developing backward Coherent Stokes Raman Scattering (CSRS) for rapid, HE-like imaging of thick tissue samples.

Subsidie
€ 2.432.705
2024

Projectdetails

Introduction

The gold-standard for cancer diagnosis is the pathological examination of Hematoxylin & Eosin (HE) stained tissue. Though well adopted worldwide for the coloration of large numbers of cancer sections, the classical HE-staining procedure is unable to provide fast feedback to surgeons within less than 30 minutes. This latency compromises the efficiency and accuracy of any tumor resection, with numerous negative impacts on the success of the surgery and the patient’s health prospects.

Current Limitations

Recently, the chemical-bond-specific image contrast provided by stimulated Raman scattering (SRS) was shown to be suitable for the generation of HE-like images. However, the SRS signal fundamentally propagates forward and is absorbed in thick biopsies, rendering SRS-based diagnosis impossible.

Furthermore, the SRS imaging speed is still too slow for the real-time determination of cancer borders in large specimens.

Proposed Solution

Here, I want to resolve these obstacles by combining the non-linear optical contrast Coherent Stokes Raman Scattering (CSRS) with high illumination angles.

  1. CSRS will permit the generation of HE-like images.
  2. It will direct the signal photons into the backward direction as a result of a unique momentum conservation law.
  3. Backward CSRS will allow for the investigation of thick cancer samples and enable technical solutions to boost the imaging speed that were never an option before.

Conclusion

Thus, the development of CSRS is not only a scientific breakthrough that circumvents the fundamental dogma of always forward scattered light but will also provide HE-like images of thick samples as real-time feedback to improve the success rate and time efficiency of cancer surgery.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.432.705
Totale projectbegroting€ 2.432.705

Tijdlijn

Startdatum1-9-2024
Einddatum31-8-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSpenvoerder

Land(en)

France

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC ADG

Vibrational speckle tomography microscopy for fast intra-operative cancer tissue histopathology

The SpeckleCARS project aims to develop fast, label-free 3D histology imaging for real-time cancer diagnosis and treatment, eliminating the need for biopsies and improving accuracy and accessibility.

€ 2.726.936
EIC Transition

Chemometric histopathology via coherent Raman imaging for precision medicine

The CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification.

€ 2.441.979
ERC ADG

In vivo Immunofluorescence-Optical Coherence Tomography

Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.

€ 2.500.000
EIC Pathfinder

Multimodal Hypersprectal Imaging and Raman Spectroscopy for Intraoperative Assessment of Breast Tumor Resection Margins

Spectra-BREAST aims to enhance tumor margin assessment in breast conserving surgery using a novel multimodal approach for real-time, accurate feedback, improving patient outcomes and reducing reoperation rates.

€ 2.990.207